GGrantIndex
← Leaderboards

Daniel J. Tschumperlin

Mayo Clinic Rochester

Google Scholar ↗PubMed ↗ORCID ↗
$19,462,790
Attributed
$24,688,843
Total exposure
14
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.5M · FY2006–25
$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$24,688,843 · 14

By mechanism

R01$20,151,474 · 7
U01$2,360,154 · 1
R21$1,269,202 · 3
R56$457,250 · 1
T32$440,763 · 1
R13$10,000 · 1

Top collaborators

Others in their field

Top investigators on “Cells”

Research focus

CellsLungFibroblastsMolecularSignal TransductionPulmonary FibrosisResponseTissuesPathway InteractionsFibrosisDepositionMechanicsExtracellular MatrixCell TypePlayProgramsIn VitroIn VivoBiologicalCollagenPhenotypeEnvironmentResolutionPathologic

Grant awards (52)

Fibrogenic activation and memory in the lung mesenchyme$596,040
R01 · FY2025 · HL · contact PI
Epithelial-Mesenchymal Interactions in Fibrosis Resolution$592,901
R01 · FY2025 · HL · contact PI
Translational Training in Respiratory Disease and Repair$440,763
T32 · FY2025 · HL · contact PI
Therapeutic ECM Resorption in Cellular Systems and Precision Cut Lung Slices.$620,489
U01 · FY2024 · HL · contact PI
Fibrogenic activation and memory in the lung mesenchyme$584,119
R01 · FY2024 · HL · contact PI
Epithelial-Mesenchymal Interactions in Fibrosis Resolution$581,043
R01 · FY2024 · HL · contact PI
Therapeutic ECM Resorption in Cellular Systems and Precision Cut Lung Slices.$633,152
U01 · FY2023 · HL · contact PI
Fibrogenic activation and memory in the lung mesenchyme$596,040
R01 · FY2023 · HL · contact PI
Epithelial-Mesenchymal Interactions in Fibrosis Resolution$592,901
R01 · FY2023 · HL · contact PI
Therapeutic modulation of zinc for lung injury and mechanobiology$689,461
R01 · FY2022 · HL
Therapeutic ECM Resorption in Cellular Systems and Precision Cut Lung Slices.$619,679
U01 · FY2022 · HL · contact PI
Mechanobiology of Lung Fibrosis$566,575
R01 · FY2022 · HL · contact PI
Mechanotransduction and YAP/TAZ Signaling in Pulmonary Arterial Hypertension$697,870
R01 · FY2021 · HL
Therapeutic modulation of zinc for lung injury and mechanobiology$691,901
R01 · FY2021 · HL
Mechanobiology of Lung Fibrosis$567,924
R01 · FY2021 · HL · contact PI
Therapeutic ECM Resorption in Cellular Systems and Precision Cut Lung Slices.$486,834
U01 · FY2021 · HL · contact PI
2021 Lung Development, Injury and Repair Gordon Research Conference and Gordon Research Seminar$10,000
R13 · FY2021 · HL · contact PI
Therapeutic modulation of zinc for lung injury and mechanobiology$694,308
R01 · FY2020 · HL
Mechanotransduction and YAP/TAZ Signaling in Pulmonary Arterial Hypertension$633,187
R01 · FY2020 · HL
Mechanobiology of Lung Fibrosis$569,472
R01 · FY2020 · HL · contact PI
Mechanotransduction and YAP/TAZ Signaling in Pulmonary Arterial Hypertension$33,237
R01 · FY2020 · HL
Therapeutic modulation of zinc for lung injury and mechanobiology$765,335
R01 · FY2019 · HL
Mechanotransduction and YAP/TAZ Signaling in Pulmonary Arterial Hypertension$634,572
R01 · FY2019 · HL
Mechanobiology of Lung Fibrosis$591,471
R01 · FY2019 · HL · contact PI
Targeting matrix stiffness in lung and liver fibrosis$532,636
R01 · FY2019 · HL · contact PI
Mechanotransduction and YAP/TAZ Signaling in Pulmonary Arterial Hypertension$669,866
R01 · FY2018 · HL
Targeting matrix stiffness in lung and liver fibrosis$538,996
R01 · FY2018 · HL · contact PI
Screening for fibroblast-selective inhibitors of YAP/TAZ$457,250
R56 · FY2018 · AG · contact PI
Mechanobiology of Lung Fibrosis$405,345
R01 · FY2018 · HL · contact PI
Targeting matrix stiffness in lung and liver fibrosis$538,996
R01 · FY2017 · HL · contact PI
Mechanobiology of Lung Fibrosis$405,345
R01 · FY2017 · HL · contact PI
Matrix remodeling in microfluidic co-culture$234,160
R21 · FY2017 · HL · contact PI
Targeting matrix stiffness in lung and liver fibrosis$540,586
R01 · FY2016 · HL · contact PI
Mechanobiology of Lung Fibrosis$405,345
R01 · FY2016 · HL · contact PI
Matrix remodeling in microfluidic co-culture$209,160
R21 · FY2016 · HL · contact PI
Mechanobiology of Lung Fibrosis$434,845
R01 · FY2015 · HL · contact PI
The resident cell in the asthmatic airway$471,842
R01 · FY2014 · HL
Screening Fibroblast-Matrix Stiffness Interactions to ID New Fibrosis Therapies$194,775
R21 · FY2014 · HL · contact PI
The resident cell in the asthmatic airway$458,360
R01 · FY2013 · HL
Screening Fibroblast-Matrix Stiffness Interactions to ID New Fibrosis Therapies$227,052
R21 · FY2013 · HL · contact PI
The resident cell in the asthmatic airway$481,470
R01 · FY2012 · HL
Mechanobiology of Lung Fibrosis$408,992
R01 · FY2012 · HL · contact PI
The resident cell in the asthmatic airway: A victim of its physical microenviron$481,470
R01 · FY2011 · HL
Mechanobiology of Lung Fibrosis$413,123
R01 · FY2011 · HL · contact PI
Mechanobiology of Lung Fibrosis$413,123
R01 · FY2010 · HL · contact PI
Mechanobiology of Lung Fibrosis$428,880
R01 · FY2009 · HL · contact PI
Molecular transduction of the mechanical environment in airway epithelium$358,299
R01 · FY2009 · HL · contact PI
Molecular transduction of the mechanical environment in airway epithelium$358,299
R01 · FY2008 · HL · contact PI
Molecular transduction of the mechanical environment in airway epithelium$358,299
R01 · FY2007 · HL · contact PI
A microrheometric assay of matrix mechanics$199,055
R21 · FY2007 · GM · contact PI
Transduction of the environment in airway epithelium$369,000
R01 · FY2006 · HL · contact PI
A microrheometric assay of matrix mechanics$205,000
R21 · FY2006 · GM · contact PI